These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1101 related articles for article (PubMed ID: 29237838)
1. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes. Yoshida A; Kawabata R; Honda T; Sakai K; Ami Y; Sakaguchi T; Irie T J Virol; 2018 Mar; 92(5):. PubMed ID: 29237838 [TBL] [Abstract][Full Text] [Related]
2. Sendai virus defective-interfering genomes and the activation of interferon-beta. Strahle L; Garcin D; Kolakofsky D Virology; 2006 Jul; 351(1):101-11. PubMed ID: 16631220 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation. Liu G; Lu Y; Liu Q; Zhou Y J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605 [TBL] [Abstract][Full Text] [Related]
4. Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA. Sánchez-Aparicio MT; Garcin D; Rice CM; Kolakofsky D; García-Sastre A; Baum A J Gen Virol; 2017 Jun; 98(6):1282-1293. PubMed ID: 28631605 [TBL] [Abstract][Full Text] [Related]
5. Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5. Mura M; Combredet C; Najburg V; Sanchez David RY; Tangy F; Komarova AV J Virol; 2017 Oct; 91(20):. PubMed ID: 28768856 [TBL] [Abstract][Full Text] [Related]
6. PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine. Ho TH; Kew C; Lui PY; Chan CP; Satoh T; Akira S; Jin DY; Kok KH J Virol; 2016 Feb; 90(3):1557-68. PubMed ID: 26608320 [TBL] [Abstract][Full Text] [Related]
7. Identification of the RNA Pseudoknot within the 3' End of the Porcine Reproductive and Respiratory Syndrome Virus Genome as a Pathogen-Associated Molecular Pattern To Activate Antiviral Signaling via RIG-I and Toll-Like Receptor 3. Xie S; Chen XX; Qiao S; Li R; Sun Y; Xia S; Wang LJ; Luo X; Deng R; Zhou EM; Zhang GP J Virol; 2018 Jun; 92(12):. PubMed ID: 29618647 [TBL] [Abstract][Full Text] [Related]
8. Defective Viral Genomes Alter How Sendai Virus Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production of Viral Particles among Infected Cells. Genoyer E; López CB J Virol; 2019 Feb; 93(4):. PubMed ID: 30463965 [TBL] [Abstract][Full Text] [Related]
9. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. Strähle L; Marq JB; Brini A; Hausmann S; Kolakofsky D; Garcin D J Virol; 2007 Nov; 81(22):12227-37. PubMed ID: 17804509 [TBL] [Abstract][Full Text] [Related]
10. Highly immunostimulatory RNA derived from a Sendai virus defective viral genome. Mercado-López X; Cotter CR; Kim WK; Sun Y; Muñoz L; Tapia K; López CB Vaccine; 2013 Nov; 31(48):5713-21. PubMed ID: 24099876 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I. Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454 [TBL] [Abstract][Full Text] [Related]
12. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. Yount JS; Gitlin L; Moran TM; López CB J Immunol; 2008 Apr; 180(7):4910-8. PubMed ID: 18354215 [TBL] [Abstract][Full Text] [Related]
13. Innate Intracellular Antiviral Responses Restrict the Amplification of Defective Virus Genomes of Parainfluenza Virus 5. Wignall-Fleming EB; Vasou A; Young D; Short JAL; Hughes DJ; Goodbourn S; Randall RE J Virol; 2020 Jun; 94(13):. PubMed ID: 32295916 [TBL] [Abstract][Full Text] [Related]
14. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner. Sooryanarain H; Heffron CL; Meng XJ mBio; 2020 Jan; 11(1):. PubMed ID: 31937650 [TBL] [Abstract][Full Text] [Related]
15. IFN-β-inducing, unusual viral RNA species produced by paramyxovirus infection accumulated into distinct cytoplasmic structures in an RNA-type-dependent manner. Yoshida A; Kawabata R; Honda T; Tomonaga K; Sakaguchi T; Irie T Front Microbiol; 2015; 6():804. PubMed ID: 26300870 [TBL] [Abstract][Full Text] [Related]
16. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling. Chang CY; Liu HM; Chang MF; Chang SC J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922 [TBL] [Abstract][Full Text] [Related]
17. Differential recognition of viral RNA by RIG-I. Baum A; García-Sastre A Virulence; 2011; 2(2):166-9. PubMed ID: 21422808 [TBL] [Abstract][Full Text] [Related]
18. Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry. Hare DN; Collins SE; Mukherjee S; Loo YM; Gale M; Janssen LJ; Mossman KL J Virol; 2015 Dec; 90(6):3018-27. PubMed ID: 26719279 [TBL] [Abstract][Full Text] [Related]
19. Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner. Linder A; Bothe V; Linder N; Schwarzlmueller P; Dahlström F; Bartenhagen C; Dugas M; Pandey D; Thorn-Seshold J; Boehmer DFR; Koenig LM; Kobold S; Schnurr M; Raedler J; Spielmann G; Karimzadeh H; Schmidt A; Endres S; Rothenfusser S Front Immunol; 2021; 12():595390. PubMed ID: 33995343 [TBL] [Abstract][Full Text] [Related]
20. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice. Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]